The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.
Drug–Induced Liver Injury: Mechanisms and Test Systems
Open accessOverview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Lemasters, J. J., Nieminen, A.-L., Qian, T., Trost, L. C., Elmore, S. P., Nishimura, Y., Crowe, R. A., Cascio, W. E., Bradham, C. A., Brenner, D. A., et al. (1998) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/s0005-2728(98)00112-1 · Cited by 1,387
Inhibition of mitochondrial beta-oxidation as a mechanism of hepatotoxicity
Fromenty, B., & Pessayre, D. (1995) · Pharmacology & Therapeutics · doi:10.1016/0163-7258(95)00012-6 · Cited by 665
Humanized xenobiotic response in mice expressing nuclear receptor SXR
Xie, W., Barwick, J. L., Downes, M., Blumberg, B., Simon, C. M., Nelson, M. C., Neuschwander-Tetri, B. A., Brunt, E. M., Guzelian, P. S., & Evans, R. M. (2000) · Nature · doi:10.1038/35019116 · Cited by 660
Macrophages and Inflammatory Mediators in Tissue Injury
Laskin, D. L., & Pendino, K. J. (1995) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pa.35.040195.003255 · Cited by 617
Self-citationMcKenzie, R., Fried, M. W., Sallie, R., Conjeevaram, H., Di Bisceglie, A. M., Park, Y., Savarese, B., Kleiner, D., Tsokos, M., Luciano, C., et al. (1995) · New England Journal of Medicine · doi:10.1056/nejm199510263331702 · Cited by 616
Self-citationMolecular Pathogenesis of Cholestasis
Trauner, M., & Jansen, P. L. M. (2004) · Springer eBooks · doi:10.1007/978-1-4419-9034-1 · Cited by 610
Stieger, B., Fattinger, K., Madon, J., Kullak-Ublick, G. A., & Meier, P. J. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70224-1 · Cited by 582
The use of single-nucleotide polymorphism maps in pharmacogenomics
McCarthy, J. J., & Hilfiker, R. (2000) · Nature Biotechnology · doi:10.1038/75360 · Cited by 434
Glucuronidation in Humans: Pharmacogenetic and Developmental Aspects
de Wildt, S. N., Kearns, G. L., Leeder, J. S., & van den Anker, J. N. (1999) · Clinical Pharmacokinetics · doi:10.2165/00003088-199936060-00005 · Cited by 393
Heterozygous non-sense mutation of the MDR3 gene in familial intrahepatic cholestasis of pregnancy
Jacquemin, E., Cresteil, D., Manouvrier, S., Boute, O., & Hadchouel, M. (1999) · The Lancet · doi:10.1016/s0140-6736(05)77221-4 · Cited by 367
Valproic acid hepatic fatalities. III. U.S. experience since 1986
Bryant, A. E., & Dreifuss, F. E. (1996) · Neurology · doi:10.1212/wnl.46.2.465 · Cited by 339
Idiosyncratic drug reactions: the reactive metabolite syndromes
Knowles, S. R., Uetrecht, J., & Shear, N. H. (2000) · The Lancet · doi:10.1016/s0140-6736(00)03137-8 · Cited by 331
Chen, C. H., Vazquez-Padua, M., & Cheng, Y. C. (1991) · Molecular Pharmacology · doi:10.1016/s0026-895x(25)11067-5 · Cited by 296
Amiodarone hepatotoxicity: Prevalence and clinicopathologic correlations among 104 patients
Lewis, J. H., Ranard, R. C., Caruso, A., Jackson, L. K., Mullick, F., Ishak, K. G., Seeff, L. B., & Zimmerman, H. J. (1989) · Hepatology · doi:10.1002/hep.1840090504 · Cited by 266
Kohlroser, J., Mathai, J., Reichheld, J., Banner, B. F., & Bonkovsky, H. L. (2000) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2000.01707.x · Cited by 209 · cited 1×
“(3) A rigorous, multicenter, active, and prospective database on drug-related hepatotoxicity would help promote basic research on hepatotoxicity and would be particularly useful in the development of pharmacogenomics, i.”
BackgroundLewis, W., Gonzalez, B., Chomyn, A., & Papoian, T. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115722 · Cited by 208
Hepatocellular Injury in a Patient Receiving Rosiglitazone: A Case Report
Al-Salman, J., Arjomand, H., Kemp, D. G., & Mittal, M. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00006 · Cited by 196
Lewis, J. H. (2000) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70287-x · Cited by 174
Yamazaki, H., Shibata, A., Suzuki, M., Nakajima, M., Shimada, N., Guengerich, F. P., & Yokoi, T. (1999) · Drug Metabolism and Disposition · doi:10.1016/s0090-9556(24)14927-6 · Cited by 161
LeSage, G., Glaser, S. S., Marucci, L., Benedetti, A., Phinizy, J. L., Rodgers, R., Caligiuri, A., Papa, E., Tretjak, Z., Jézéquel, A.-M., et al. (1999) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1999.276.5.g1289 · Cited by 153
Fulminant hepatitis with severe lactate acidosis in HIV‐infected patients on didanosine therapy
Bissuel, F., Bruneel, F., Habersetzer, F., CHASSARD, D., Cotte, L., Chevallier, M., Bernuau, J., Lucet, J. C., & TREPO, C. G. (1994) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.1994.tb01088.x · Cited by 135
Wang, X., Kanel, G. C., & DeLeve, L. D. (2000) · Hepatology · doi:10.1002/hep.510310224 · Cited by 130
Cui, L., Yoon, S.-S., Schinazi, R. F., & Sommadossi, J. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117698 · Cited by 120
Latta, M. R., Künstle, G., Leist, M., & Wendel, A. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.191.11.1975 · Cited by 115
CASE REPORT: Troglitazone-Induced Fulminant Hepatic Failure
Murphy, E. J., Davern, T. J., Shakil, A. O., Shick, L., Masharani, U., Chow, H., Freise, C., Lee, W. M., & Bass, N. M. (2000) · Digestive Diseases and Sciences · doi:10.1023/a:1005405526283 · Cited by 111
Antiviral activity and toxicity of fialuridine in the woodchuck model of hepatitis B virus infection
Tennant, B. C., Baldwin, B. H., Graham, L. A., Ascenzi, M., Hornbuckle, W. E., Rowland, P. H., Tochkov, I. A., Yeager, A. E., Erb, H. N., Colacino, J. M., et al. (1998) · Hepatology · doi:10.1002/hep.510280124 · Cited by 103
Hentze, H., Gantner, F., Kolb, S., & Wendel, A. (2000) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65076-6 · Cited by 69
Glutathione Defense in Non-Parenchymal Cells
DeLeve, L. D. (1998) · Seminars in Liver Disease · doi:10.1055/s-2007-1007173 · Cited by 67
Guengerich, F. P., Hosea, N. A., Parikh, A., Bell, L. C., Johnson, W. W., Gillam, E. M. J., & Shimada, T. (1998) · PubMed · Cited by 67
Cytokine-mediated hepatic apoptosis
Leist, M., Gantner, F., Künstle, G., & Wendel, A. (1998) · Springer eBooks · doi:10.1007/bfb0000614 · Cited by 65
Bautista, A. P. (2000) · Journal of Gastroenterology and Hepatology · doi:10.1046/j.1440-1746.2000.02174.x · Cited by 62
(1997) · PubMed · Cited by 59
Fialuridine accumulates in DNA of dogs, monkeys, and rats following long-term oral administration
Richardson, F. C., Engelhardt, J. A., & Bowsher, R. R. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.25.12003 · Cited by 58
Mitochondria and Childhood Liver Diseases
Sokol, R. J., & Treem, W. R. (1999) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1002/j.1536-4801.1999.tb01995.x · Cited by 57
III. Intracellular signaling in response to toxic liver injury
Jones, B., & Czaja, M. J. (1998) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.1998.275.5.g874 · Cited by 48
Valproate inhibits the mitochondrial pyruvate‐driven oxidative phosphorylation in vitro
Silva, M. F. B., Ruiter, J. P. N., IJlst, L., Jakobs, C., Durán, M., de Almeida, I. T., & Wanders, R. J. A. (1997) · Journal of Inherited Metabolic Disease · doi:10.1023/a:1005398516208 · Cited by 46
Fukano, M., Amano, S., Sato, J., Yamamoto, K., Adachi, H., Okabe, H., Fujiyama, Y., & Bamba, T. (2000) · Human Pathology · doi:10.1016/s0046-8177(00)80229-4 · Cited by 42
Modulation of tolerance by mutant heat shock transcription factors.
Xia, W., Vilaboa, N. E., Martin, J. W., et al. (1999) · PubMed · doi:10.1006/csac.1998.0113 · Cited by 42
Cited by
Lee, W. M. (2003) · New England Journal of Medicine · doi:10.1056/nejmra021844 · Cited by 1,594
van Leth, F., Phanuphak, P., Ruxrungtham, K., Baraldi, E., Miller, S., Gazzard, B., Cahn, P., Lalloo, U., van der Westhuizen, I., Malan, D., et al. (2004) · The Lancet · doi:10.1016/s0140-6736(04)15997-7 · Cited by 684
Merkel, T. J., Jones, S. W., Herlihy, K. P., Kersey, F. R., Shields, A. R., Napier, M., Luft, J. C., Wu, H., Zamboni, W. C., Wang, A. Z., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1010013108 · Cited by 548
Huang, Y.-S., Chern, H.-D., Su, W.-J., Wu, J.-C., Lai, S.-L., Yang, S.-Y., Chang, F.-Y., & Lee, S.-D. (2002) · Hepatology · doi:10.1053/jhep.2002.32102 · Cited by 432
Identifying genetic risk factors for serious adverse drug reactions: current progress and challenges
Wilke, R. A., Lin, D. W., Roden, D. M., Watkins, P. B., Flockhart, D., Zineh, I., Giacomini, K. M., & Krauss, R. M. (2007) · Nature Reviews Drug Discovery · doi:10.1038/nrd2423 · Cited by 391
Metadata
- Authors
- Bissell, M. D., Gores, G. J., Laskin, D. L., & Hoofnagle, J. H.
- Venue
- Hepatology
- Published
- 2001-04
- Volume
- 33
- Issue
- 4
- Pages
- 1009-1013
- ISSN
- 0270-9139 (ISSN-L)
- OpenAlex
- W2116175407
- Cited by
- 267
- References
- 38
- FWCI
- 7.43
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.